Crestwood Advisors Group’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.77M Sell
85,594
-4,880
-5% -$445K 0.12% 124
2026
Q1
$9.29M Sell
90,474
-816
-0.9% -$92.1K 0.16% 109
2025
Q4
$11.4M Buy
91,290
+784
+0.9% +$99.9K 0.19% 94
2025
Q3
$12.1M Sell
90,506
-5
-0% -$656 0.21% 89
2025
Q2
$12.3M Sell
90,511
-1,304
-1% -$172K 0.22% 90
2025
Q1
$12.2M Buy
91,815
+2,298
+3% +$292K 0.23% 86
2024
Q4
$10.1M Buy
89,517
+1,515
+2% +$175K 0.19% 97
2024
Q3
$10M Buy
88,002
+1,620
+2% +$178K 0.19% 94
2024
Q2
$8.98M Sell
86,382
-2,391
-3% -$254K 0.19% 93
2024
Q1
$10.1M Buy
88,773
+8,774
+11% +$1.01M 0.22% 84
2023
Q4
$8.81M Buy
79,999
+1,255
+2% +$125K 0.21% 89
2023
Q3
$7.63M Sell
78,744
-928
-1% -$97.5K 0.2% 91
2023
Q2
$8.69M Sell
79,672
-31,533
-28% -$3.36M 0.27% 65
2023
Q1
$11.3M Sell
111,205
-9,481
-8% -$1M 0.38% 68
2022
Q4
$13.3M Buy
120,686
+378
+0.3% +$39.1K 0.45% 64
2022
Q3
$11.6M Buy
120,308
+981
+0.8% +$105K 0.41% 68
2022
Q2
$13M Buy
119,327
+2,841
+2% +$323K 0.44% 65
2022
Q1
$13.8M Sell
116,486
-899
-0.8% -$111K 0.39% 68
2021
Q4
$16.5M Buy
117,385
+822
+0.7% +$105K 0.43% 61
2021
Q3
$13.8M Sell
116,563
-185
-0.2% -$22.7K 0.39% 68
2021
Q2
$13.5M Buy
116,748
+851
+0.7% +$99.2K 0.39% 67
2021
Q1
$13.9M Sell
115,897
-94
-0.1% -$11.1K 0.44% 67
2020
Q4
$12.7M Sell
115,991
-2,145
-2% -$233K 0.42% 66
2020
Q3
$12.9M Buy
118,136
+760
+0.6% +$77.1K 0.48% 65
2020
Q2
$10.7M Buy
117,376
+7,670
+7% +$693K 0.43% 67
2020
Q1
$8.66M Sell
109,706
-3,766
-3% -$314K 0.43% 66
2019
Q4
$9.86M Sell
113,472
-230
-0.2% -$19.3K 0.39% 69
2019
Q3
$9.51M Buy
113,702
+323
+0.3% +$27.4K 0.42% 67
2019
Q2
$9.54M Buy
+113,379
New +$8.92M 0.43% 68
2017
Q2
Sell
-680
Closed -$30K 163
2017
Q1
$30K Buy
+680
New +$29.4K ﹤0.01% 326
2014
Q3
Sell
-6,287
Closed -$257K 126
2014
Q2
$257K Sell
6,287
-5,262
-46% -$207K 0.04% 105
2014
Q1
$445K Buy
+11,549
New +$445K 0.07% 78

Other funds holding ABT

Crestwood Advisors Group's ABT Position: Q2 2026 in Review

Crestwood Advisors Group reduced its Abbott (ABT) stake by 5.4% in Q2 2026, selling an estimated $445K and leaving 85,594 shares worth $7.77M. The position accounts for 0.12% of the portfolio, ranked #124.

Crestwood Advisors Group first reported a position in ABT in Q1 2014 and has held it in 32 quarters since. The position peaked at $16.5M in Q4 2021. 2,956 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Crestwood Advisors Group held 85,594 shares of Abbott worth $7.77M as of Q2 2026.
  • Crestwood Advisors Group sold 4,880 Abbott shares in Q2 2026, an estimated $445K.
  • Abbott made up 0.12% of Crestwood Advisors Group's portfolio in Q2 2026, its #124 holding.
  • Crestwood Advisors Group first reported a position in Abbott in Q1 2014 and has held it in 32 quarters since.
  • Crestwood Advisors Group's Abbott position peaked at $16.5M in Q4 2021.
  • 2,956 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.